Cytokines in the treatment of leishmaniasis: immunopathology to patient therapy From studies of

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin 12 and tumor necrosis factor a are costimulators of interferon y production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

  2005cited by this paper
• Interleukin‐4 transgenic mice of resistant background are susceptible to Leishmania major infection

  1993cited by this paper
• Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide

  1993cited by this paper
• Natural Killer Cell Stimulatory Factor (Interleukin 12 (11,12)) Induces T Helper Type 1 (Thl)-specific Immune Responses and Inhibits the Development of ID4-producing Th Cells By Roberto Manetti, Paola Parronchi, Maria Grazia Giudizi,

  1993cited by this paper
• Chemically modified antigen preferentially elicits induction of Th1- like cytokine synthesis patterns in vivo

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

  1993cited by this paper
• Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi.

  1993cited by this paper
• Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm.

  1993cited by this paper
• Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

  1993cited by this paper
• Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

  1993cited by this paper
• Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis

  1993cited by this paper
• Cytokine patterns in the pathogenesis of human leishmaniasis.

  1993cited by this paper
• Recombinant interleukin 12 cures mice infected with Leishmania major

  1993cited by this paper
• Leishmania major interferes with antigen presentation by infected macrophages.

  1993cited by this paper
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

  1993cited by this paper
• Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

  1993cited by this paper
• IL-12: initiation cytokine for cell-mediated immunity.

  1993cited by this paper
• Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins.

  1993cited by this paper
• The Role of Interferon-γ in the Treatment of Visceral and Diffuse Cutaneous Leishmaniasis

  1993cited by this paper
• Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction

  1993cited by this paper
• Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C.

  1992cited by this paper
• IL-4 induces a Th2 response in Leishmania major-infected mice.

  1992cited by this paper
• In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates

  1992cited by this paper
• Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

  1992cited by this paper
• Phagocytosis of Giardia lamblia trophozoites by cytokine‐activated macrophages

  1992cited by this paper
• Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

  1992cited by this paper
• Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism

  1992cited by this paper
• Use of immune modulators in nonspecific therapy of bacterial infections

  1992cited by this paper
• Allopurinol in the treatment of American cutaneous leishmaniasis.

  1992cited by this paper
• Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

  1992cited by this paper
• Estimation of population at risk of infection and number of cases of Leishmaniasis.

  1992cited by this paper
• Interleukin 1: an important mediator of host resistance against Pneumocystis carinii

  1992cited by this paper
• Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.

  1992cited by this paper
• IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.

  1992cited by this paper
• Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro

  1992cited by this paper
• Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection

  1992cited by this paper
• Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

  1992cited by this paper
• Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.

  1992cited by this paper
• Nitric oxide as a secretory product of mammalian cells

  1992cited by this paper
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

  1992cited by this paper
• Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.

  1992cited by this paper
• Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

  1991cited by this paper
• Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

  1991cited by this paper
• Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease.

  1991cited by this paper
• Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease.

  1991cited by this paper
• Prophylaxis or treatment of experimental brucellosis with interleukin-1

  1991cited by this paper
• Modulation of Mycobacterium avium Growth in Murine Macrophages: Reversal of Unresponsiveness to Interferon‐Gamma by Indomethacin or Interleukin‐4

  1991cited by this paper
• Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

  1991cited by this paper
• Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages.

  1991cited by this paper
• Endogenous Interferon-γ, Macrophage Activation, and Murine Host Defense against Acute Infection with Trypanosoma cruzi

  1991cited by this paper
• Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.

  1991cited by this paper
• Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

  1990cited by this paper
• Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

  1990cited by this paper
• Bacterial infections in patients with visceral leishmaniasis.

  1990cited by this paper
• Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells

  1990cited by this paper
• Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells

  1990cited by this paper
• Role of TNF and IL-1 in infections with Toxoplasma gondii.

  1990cited by this paper
• Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.

  1990cited by this paper
• Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells

  1990cited by this paper
• Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1

  1990cited by this paper
• Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis.

  1990cited by this paper
• Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages.

  1990cited by this paper
• Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis

  1990cited by this paper
• Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

  1990cited by this paper
• Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

  1990cited by this paper
• Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron.

  1989cited by this paper
• Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity

  1989cited by this paper
• Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.

  1989cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Transforming growth factor beta.

  1988cited by this paper
• Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta

  1988cited by this paper
• Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages

  1988cited by this paper
• Cytokine activation of antibacterial activity in human pulmonary macrophages: comparison of recombinant interferon-gamma and granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

  1988cited by this paper
• Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

  1988cited by this paper
• In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis.

  1988cited by this paper
• Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma

  1987cited by this paper
• Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.

  1987cited by this paper
• Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

  1987cited by this paper
• Macrophage activation for antileishmanial defense by an apparently novel mechanism.

  1987cited by this paper
• Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages

  1987cited by this paper
• Granulocyte monocyte colony stimulating factor activates human macrophages to kill mycobacterium avium complex

  1987cited by this paper
• Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells.

  1986cited by this paper
• Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

  1986cited by this paper
• New perspectives on a subclinical form of visceral leishmaniasis.

  1986cited by this paper
• Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.

  1986cited by this paper
• Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide.

  1985cited by this paper
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

  1985cited by this paper
• Human cutaneous leishmaniasis acquired in Texas.

  1985cited by this paper
• Lone laryngeal leishmaniasis.

  1985cited by this paper
• Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

  1985cited by this paper
• Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.

  1985cited by this paper
• Clinical manifestations, diagnosis and treatment of leishmaniasis.

  1985cited by this paper
• Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.

  1985cited by this paper
• Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

  1984cited by this paper
• Activation of human macrophages. Comparison of other cytokines with interferon-gamma

  1984cited by this paper
• Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.

  1984cited by this paper
• Selective primary health care: strategies for control of disease in the developing world. XI. Dengue.

  1984cited by this paper
• Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon

  1984cited by this paper

• Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor.

  1996cites this paper
• Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.

  1995cites this paper